Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Nieuwe NVALT-richtlijn Aandoeningen van de Pleura
sep 2019 | Longoncologie